Impact of Factors 9 and IFN-I levels on MDS prognosis.
a, Kaplan-Meier plots for the BMMNC cohort where patients were split based on low (1st quartile), medium (2nd and 3rd quartile), and high (4th quartile) levels of Factor 9. b, The absolute loading of the top three features affecting Factor 9 in RTEs expression view in the BMMNC cohort. c, Kaplan-Meier plots where patients were split into quartiles (top 25%, bottom 25% and middle 50%) for survival analyses depending on their IFN-I signature score levels in the BMMNC, RNA-seq CD34+, and Microarray CD34+ cohorts. All p-values were calculated using log-rank test on overall and event-free survival values of high versus low groups.